SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-013234
Filing Date
2021-05-28
Accepted
2021-05-28 17:11:19
Documents
12
Period of Report
2021-05-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43118
  Complete submission text file 0001493152-21-013234.txt   216349

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abeo-20210526.xsd EX-101.SCH 3053
3 XBRL LABEL FILE abeo-20210526_lab.xml EX-101.LAB 34238
4 XBRL PRESENTATION FILE abeo-20210526_pre.xml EX-101.PRE 22377
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3607
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 21981558
SIC: 2834 Pharmaceutical Preparations